A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.
from News-Medical.Net Child Health News Feed https://ift.tt/2oFjos7
0 Comments